Screening
53 approved drugs that may block Ebola infection
Study identifies 53 approved drugs that may block Ebola infection — Compounds may keep virus from entering cells; may accelerate drug development – Researchers found 53 existing drugs that may keep the Ebola virus from entering human cells, a key step in the process of infection. Among the better known drug types shown to hinder infection by an Ebola virus model: several cancer drugs, antihistamines and antibiotics.
New Ebola screening to start at 5 airports in US
Five U.S. Airports Are Enacting New Screening Measures to Protect Against Ebola – The Centers for Disease Control and Prevention (CDC), USA and the Department of Homeland Security (DHS), USA announced that the following five U.S. airports will soon begin enhanced Ebola screening for all travelers coming from Ebola-affected countries
Tighter Ebola Screening for Travelers From West Africa – Obama
U.S. working on new screenings for Ebola but no travel ban — U.S. will augment Ebola screenings for airline passengers in U.S. and Africa – U.S. President Barack Obama met with members of his national security team and senior staff to receive an update on the Ebola outbreak in West Africa and the administration’s response efforts at the White House in Washington October 6, 2014.
US Travel Warning to avoid travel to West African nations
As West Africa Ebola outbreak worsens, CDC issues Level 3 Travel Warning — CDC surge scaling up response in Guinea, Sierra Leone, and Liberia – The Centers for Disease Control and Prevention (CDC) issued a warning to avoid nonessential travel to the West African nations of Guinea, Liberia, and Sierra Leone. This Level 3 travel warning is a reflection of the worsening Ebola outbreak in this region.
New blood test predicts breast cancer risk
New test predicts the risk of non-hereditary breast cancer — A simple blood test is currently in development that could help predict the likelihood of a woman developing breast cancer – A simple blood test is currently in development that could help predict the likelihood of a woman developing breast cancer, even in the absence of a high-risk BRCA1 gene mutation. This new research is published in the Genome Medicine.